LC/MS
<a href="https://www.bioagilytix.com/blog/category/drug-development/">Drug Development</a>
GLP-1 and Metabolic Peptide Therapeutics: Bioanalytical Strategy is a Key Factor in Drug Development
The GLP-1 revolution has reshaped the metabolic disease landscape, and the pipeline behind semaglutide and tirzepatide continues to expand at an unprecedented pace. Sponsors are…